By Scott Graham | May 16, 2019
Durie Tangri's Mark Lemley, an attorney for a would-be class of consumers and insurers, says a 2015 ruling on a Spider-Man toy established limits on royalties that drug companies are ignoring.
Delaware Business Court Insider | News
By Tom McParland | May 15, 2019
Under the agreement, Boehringer will to pay AbbVie royalties for licensing its Humira patents and agreed to acknowledges the validity and enforceability of the patents, AbbVie said.
By Tom McParland | May 14, 2019
According to the letter, Goldman made more than $580 million for advising the company at the heart of the scandal over the course of 12 months, a rate that was 200 times the typical fee for such transactions. Now the company expects to spend $1.9 billion more than it had initially reserved to defend legal matters related to the scandal, according to the 27-page correspondence.
By Tom McParland | May 14, 2019
According to the letter, Goldman made more than $580 million for advising the company at the heart of the scandal over the course of 12 months, a rate that was 200 times the typical fee for such transactions. Now the company expects to spend $1.9 billion more than it had initially reserved to defend legal matters related to the scandal, according to the 27-page correspondence.
By Max Mitchell | May 13, 2019
The filing earlier this year for bankruptcy protection of Imerys, the talc supplier to Johnson & Johnson, led the consumer products manufacturer to remove to federal court thousands of talc cases—many of which had been gearing up for trial.
By Robert Storace | May 13, 2019
Connecticut is leading a 44-state coalition, alleging price-fixing by 20 makers of generic drugs. Their lawsuit seeks payments of billions of dollars to these states.
Delaware Business Court Insider | News
By Tom McParland | May 10, 2019
Judge Abigail M. LeGrow on Thursday ruled that the claims by plaintiff P&TI Acquisition Co. failed because the firm had failed to show that managers associated with a Morgenthaler-related firm controlled the entities by virtue of either their voting or decision-making power.
Delaware Business Court Insider | News
By Tom McParland | May 8, 2019
The opinion represented a mixed result for both Dole and its insurers on competing motions for summary judgment in the case, which stemmed from two settlements resolving shareholder claims that Dole and its president and CEO, David H. Murdock, had manipulated the company's stock price when Murdock took Dole private in 2013.
By Tom McParland | May 8, 2019
"The state continues to press its strategy of having two courts litigate the same constitutional challenges to the same Delaware statutes at the same time," the vice chancellor said.
Delaware Business Court Insider | News
By Scott Graham | May 7, 2019
Judge Joseph Bataillon says he will enjoin L'Oreal from marketing products that infringe a patent held by Olaplex LLC—notwithstanding a Patent Trial and Appeal Board decision finding the patent invalid.
Presented by BigVoodoo
This event shines a spotlight on the individuals, teams, projects and organizations that are changing the financial industry.
BTI provides leading tax professionals from financial institutions with unmatched tools and resources.
Honoring outstanding legal achievements focused at the national level, largely around Big Law and in-house departments.
COLE SCHOTZ P.C.COMMERCIAL REAL ESTATE PARALEGAL- NEW YORK OR NEW JERSEY OFFICES: Prominent mid-Atlantic law firm with multiple regional of...
Our client, a small but highly sophisticated and entrepreneurial tax boutique in Charleston, SC, has asked for our firm s assistance in iden...
CORE RESPONSIBILITIES AND TASKS:(1) Tasks and responsibilities include:Reviewing and negotiating commercial agreements for internal business...